CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56,985 enrolled
Drug / intervention
extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01400217
NCT01400217N/ACompleted
CompareCT.gov

HFA Beclomethasone in Asthma, a General Practice Research Database Study: Real-life Observational Evaluation of Extra-fine With Standard Particle Size Beclometasone Dipropionate Using the Propellant Hydrofluoroalkane 134a for the Management of Asthma in a Representative UK Primary Care Population

Research in Real-Life Ltd·observational·Posted Jul 22, 2011·Updated Oct 30, 2012

In Brief

An observational study evaluating extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler and standard particle particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler for Asthma. Completed, enrolled 56,985 participants across 1 site.

Detailed Summary

This study will compare the absolute and relative effectiveness of asthma management in patients on inhaled corticosteroid (ICS) maintenance therapy as either extra-fine-particle or larger-particle formulation beclomethasone dipropionate (BDP) via metered-dose inhalers (MDIs) using the propellant hydrofluoroalkane propellant (HFA-BDP), namely Qvar® MDI compared with Clenil® MDI.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom
CollaboratorsTeva Branded Pharmaceutical Products R&D, Inc.

Timeline

N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 22, 2011
Enrollment StartJan 1, 1991
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 19.8 yearsPosted 14.9 years ago

Interventions

extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhalerdrug

IPDI cohort intervention = initiation of intervention drug; IPDS cohort intervention = switching from baseline inhaled corticosteroid therapy to intervention drug without a change in baseline inhaled corticosteroid dose; IPDA cohort intervention = increase in baseline inhaled corticosteroid drug as intervention drug

standard particle particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhalerdrug

IPDI cohort intervention = initiation of intervention drug; IPDS cohort intervention = switching from baseline inhaled corticosteroid therapy to intervention drug without a change in baseline inhaled corticosteroid dose; IPDA cohort intervention = increase in baseline inhaled corticosteroid drug as intervention drug